Rodyti straipsnį

Vidutinė ir lengva beta talasemija

Palaikomoji priežiūra

Geležies chelacija

Iron out for nontransfused thalassemia. (atsiveria naujas langas)

Marks PW.

Šaltinis‎: Blood 2012;120(5):928-9.

Kodas‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (atsiveria naujas langas)

Iron overload in β-thalassemia intermedia: an emerging concern. (atsiveria naujas langas)

Musallam KM, Cappellini MD, Taher AT.

Šaltinis‎: Curr Opin Hematol 2013;20(3):187-92.

Kodas‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (atsiveria naujas langas)

Maisto papildai ir kitos palaikomosios terapijos

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (atsiveria naujas langas)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Šaltinis‎: Blood 2012;120(7):1531-2.

Kodas‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (atsiveria naujas langas)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (atsiveria naujas langas)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Šaltinis‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Kodas‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (atsiveria naujas langas)

Therapeutic roles of curcumin: lessons learned from clinical trials. (atsiveria naujas langas)

Gupta SC, Patchva S, Aggarwal BB.

Šaltinis‎: AAPS J 2013;15(1):195-218.

Kodas‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (atsiveria naujas langas)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (atsiveria naujas langas)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Šaltinis‎: J Med Assoc Thai 2012;95(1):29-36.

Kodas‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (atsiveria naujas langas)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (atsiveria naujas langas)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Šaltinis‎: Am J Hematol 2013;88(6):503-6.

Kodas‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (atsiveria naujas langas)